[Federal Register Volume 64, Number 103 (Friday, May 28, 1999)] [Notices] [Page 29051] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 99-13592] [[Page 29051]] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Recombinant DNA Advisory Committee; Notice of Meeting Pursuant to Pub. L. 92-463, notice is hereby given of a meeting of the Recombinant DNA Advisory Committee, Building 31C, 6th Floor, Conference Room 10, 9000 Rockville Pike, Bethesda, Maryland 20892, starting on June 14, 1999, at approximately 9 a.m., and will recess at approximately 5 p.m. The meeting will be open to the public. Agenda items will include: (1) Discussion of novel phase 1 gene transfer protocol for pediatric retinoblastoma, (2) Food and Drug Administration presentation on vector gonadal distribution and inadvertent germ line gene transfer, (3) data management activities related to human gene transfer clinical trials, and (4) other matters to be considered by the Committee. Attendance by the public will be limited to space available. Debra W. Knorr, Acting Director, Office of Recombinant DNA Activities, National Institutes of Health, MSC 7010, 6000 Executive Boulevard, Suite 302, Bethesda, Maryland 20892-7010, Phone (301) 496- 9838, FAX (301) 496-9839, will provide summaries of the meeting and a roster of committee members upon request. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should contact Ms. Knorr in advance of the meeting. The Office of Recombinant DNA Activities (ORDA) web site is located at http://www.nih.gov/od/orda for further information about the office. OMB's ``Mandatory Information Requirements for Federal Assistance Program Announcements'' (45 FR 39592, June 11, 1980) requires a statement concerning the official government programs contained in the Catalog of Federal Domestic Assistance. Normally NIH lists in its announcements the number and title of affected individual programs for the guidance of the public. Because the guidance in this notice covers virtually every NIH and Federal research program in which DNA recombinant molecule techniques could be used, it has been determined not to be cost effective or in the public interest to attempt to list these programs. Such a list would likely require several additional pages. In addition, NIH could not be certain that every Federal program would be included as many Federal agencies, as well as private organizations, both national and international, have elected to follow the NIH Guidelines. In lieu of the individual program listing, NIH invites readers to direct questions to the information address above about whether individual programs listed in the Catalog of Federal Domestic Assistance are affected. Dated: May 20, 1999. LaVerne Y. Stringfield, Committee Management Officer, NIH. [FR Doc. 99-13592 Filed 5-27-99; 8:45 am] BILLING CODE 4140-01-M